P3 Health Partners reports Q1 net income $3M, raises FY 2026 adjusted EBITDA guidance to $20-60M

P3 Health Partners Inc.

2026-Q1 EPS reported $0.32 revenue$386,390,000

Q1 revenue $386M (+4% YoY); net income $3M vs net loss $44.2M prior year.
Adjusted EBITDA $25.8M ($81 PMPM); cites contract restructuring and operational redesign.
At-risk membership ~106,000, down 10% YoY due to intentional network rationalization.
Full-year 2026 adjusted EBITDA guidance raised to $20-$60M (midpoint $40M).
Medical margin $73.7M; excluding prior-year development and settlements $56.1M.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.4

P3 Health Partners Inc. reported financial results for the first quarter ended March 31, 2026.

Period: the first quarter ended March 31, 2026
Result: reported results

Exact text from the filing

On May 14, 2026, P3 Health Partners Inc. (the "Company") announced its financial results for the three months ended March 31, 2026. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K (the "Report").

View on SEC.gov

13 earnings releases filed in the last 30 days. Browse all earnings releases →

P3 Health Partners Inc. filing history →

Source: SEC EDGAR

accession 0001832511-26-000021

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.